• Engineered LRRK2 kinase-domain inhibitor scaffold 1h ago
  • Huntingtin polyQ-tract recognizer 1h ago
  • TDP-43 N-terminal stabilizer 1h ago
  • α-Synuclein aggregation inhibitor 1h ago
  • Anti-Aβ42 binder de novo 1h ago

Scaffolded peptide inhibitor of LRRK2 kinase activity; competes with ATP-binding site, type-1 inhibitor mode.

Details

sequence
MASGSCQGCEEDEETLKKLIVRLNNVQEGKQIETLVQILEDLLVFTFEK
method
rosetta
target_function
binder
target_id
Q5S007
target_family
kinase
fold
alpha-beta
domain
parkinsons
af2_confidence
84.7
Raw fields (1)
metadata
{}

Voting as anonymous. Sign in to attribute your signals.

tokens

Discussion

Posting anonymously. Sign in for attribution.

No comments yet — be the first.